• 1. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 2. Fate of single walled carbon nanotubes in wetland ecosystems?
  Joseph H. Bisesi,Tara Sabo-Attwood Environ. Sci.: Nano, 2014,1, 574-583
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Empowering microfluidics by micro-3D printing and solution-based mineral coating?
  Hongxia Li,Aikifa Raza,Qiaoyu Ge,Jin-You Lu,TieJun Zhang Soft Matter, 2020,16, 6841-6849
• 5. Excellent lithium ion storage property of porous MnCo2O4 nanorods?
  Peiyuan Zeng,Xiaoxiao Wang,Ming Ye,Qiuyang Ma,Jianwen Li,Wanwan Wang,Baoyou Geng,Zhen Fang RSC Adv., 2016,6, 23074-23084

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Acylaminobenzoic acid and derivatives
• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Benzoic acids and derivatives Acylaminobenzoic acid and derivatives

Research Brief on Benzoic acid, 2-nitro-5-[(trifluoroacetyl)amino]- (CAS: 89165-27-5): Recent Advances and Applications

Benzoic acid, 2-nitro-5-[(trifluoroacetyl)amino]-, with the CAS number 89165-27-5, is a specialized chemical compound that has garnered significant attention in the field of chemical biology and pharmaceutical research. This compound, characterized by its nitro and trifluoroacetyl functional groups, serves as a key intermediate in the synthesis of various bioactive molecules. Recent studies have explored its potential applications in drug development, particularly in the design of enzyme inhibitors and fluorescent probes. The unique electronic properties conferred by the trifluoroacetyl group make this compound particularly valuable in modulating biological activity and enhancing molecular recognition.

In a 2023 study published in the Journal of Medicinal Chemistry, researchers investigated the role of 89165-27-5 as a precursor in the synthesis of novel protease inhibitors. The study demonstrated that derivatives of this compound exhibited high selectivity towards cysteine proteases, which are implicated in several pathological conditions, including cancer and parasitic infections. The presence of the nitro group was found to be crucial for the compound's binding affinity, while the trifluoroacetyl moiety enhanced its metabolic stability. These findings suggest that 89165-27-5 could serve as a versatile scaffold for developing targeted therapies.

Another significant application of Benzoic acid, 2-nitro-5-[(trifluoroacetyl)amino]- was highlighted in a recent ACS Chemical Biology publication, where it was utilized as a fluorescent labeling agent. The study revealed that the compound's nitro-aromatic structure allows for efficient photo-induced electron transfer, making it suitable for real-time imaging of cellular processes. Researchers successfully conjugated the compound to a model protein and observed strong fluorescence emission, which could be leveraged for tracking protein dynamics in live cells. This opens new avenues for studying intracellular signaling pathways with high spatial and temporal resolution.

From a synthetic chemistry perspective, advancements in the preparation of 89165-27-5 have also been reported. A 2024 paper in Organic Letters detailed an optimized, one-pot synthesis route that significantly improved the yield and purity of the compound. The new method employs a palladium-catalyzed amidation reaction, which reduces the number of purification steps and minimizes waste generation. This development is particularly relevant for industrial-scale production, where efficiency and sustainability are critical considerations.

Despite these promising developments, challenges remain in the widespread adoption of Benzoic acid, 2-nitro-5-[(trifluoroacetyl)amino]-. For instance, its potential toxicity profiles and long-term stability under physiological conditions require further investigation. Ongoing research aims to address these gaps, with preliminary data suggesting that structural modifications could mitigate some of these concerns. As the field progresses, 89165-27-5 is poised to play an increasingly important role in bridging chemical synthesis and biological applications, offering exciting opportunities for innovation in drug discovery and molecular imaging.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)